X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-11-11 | CTLT | Ryan Michelle R | Dir | S - Sale | $59.70 | -2,800 | 10,835 | -21% | -$167,160 | ||||||
2024-10-18 | CTLT | Ferraro Joseph Anthony | SVP, GC, CCO | S - Sale | $59.97 | -320 | 23,967 | -1% | -$19,190 | ||||||
2024-09-26 | CTLT | McErlane David | Group Pres, Biologics | S - Sale | $59.97 | -1,994 | 36,304 | -5% | -$119,580 | ||||||
2024-08-02 | CTLT | Hopson Ricky | Pres BioProduct Delivery, CoS | S - Sale | $59.56 | -662 | 29,974 | -2% | -$39,429 | ||||||
2024-08-02 | CTLT | Gunther Scott | SVP, Quality, Reg. Affairs | S - Sale | $59.55 | -666 | 39,635 | -2% | -$39,660 | ||||||
2024-08-02 | CTLT | Ferraro Joseph Anthony | SVP, GC, CCO | S - Sale | $59.58 | -608 | 24,287 | -2% | -$36,225 | ||||||
2024-08-02 | CTLT | Evoli Lisa | SVP, CHRO | S - Sale | $59.67 | -3,859 | 39,366 | -9% | -$230,267 | ||||||
2024-08-02 | CTLT | Gennadios Aristippos | Group Pres Pharma, Consumer | S - Sale | $59.55 | -1,169 | 113,724 | -1% | -$69,614 | ||||||
2024-07-29 | CTLT | Maselli Alessandro | Pres, CEO | S - Sale | $58.76 | -9,088 | 177,521 | -5% | -$534,011 | ||||||
2024-07-29 | CTLT | Hopson Ricky | Pres BioProduct Delivery, CoS | S - Sale | $58.67 | -206 | 30,636 | -1% | -$12,086 | ||||||
2024-07-29 | CTLT | Gunther Scott | SVP, Quality, Reg. Affairs | S - Sale | $58.69 | -283 | 40,301 | -1% | -$16,609 | ||||||
2024-07-29 | CTLT | Gennadios Aristippos | Group Pres Pharma, Consumer | S - Sale | $58.70 | -349 | 114,893 | 0% | -$20,486 | ||||||
2024-07-08 | CTLT | Masanovich Matti | SVP, CFO | S - Sale | $56.74 | -2,993 | 33,871 | -8% | -$169,823 | ||||||
2024-06-04 | CTLT | Hopson Ricky | Pres BioProduct Delivery, CoS | S - Sale | $54.26 | -1,401 | 20,617 | -6% | -$76,023 | ||||||
2024-03-15 | CTLT | Gunther Scott | SVP, Quality, Reg. Affairs | S - Sale | $56.20 | -387 | 29,506 | -1% | -$21,749 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |